Severe withdrawal syndrome possibly associated with cessation of a midazolam and fentanyl infusion.

Abstract:

:A 40-month-old child was sedated with a fentanyl and midazolam infusion for 7 days. After the drugs were discontinued he became unresponsive and globally aphasic, and had marked thrombocytosis. He was hospitalized for 4 weeks, during which time his motor and cognitive status slowly improved, and had almost returned to baseline at time of discharge. Severe neurologic abnormalities have been reported with midazolam and fentanyl, administered separately or together, and seem to be a consequence of a withdrawal syndrome. Of interest, this patient had a reactive thrombocytosis at the time of onset of the withdrawal syndrome, and his decreased platelet count coincided with the return to normal cognitive and motor status. Based on this experience and other reports, we believe midazolam-fentanyl combination should be administered with caution.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Ducharme MP,Munzenberger P

doi

10.1002/j.1875-9114.1995.tb02877.x

subject

Has Abstract

pub_date

1995-09-01 00:00:00

pages

665-8

issue

5

eissn

0277-0008

issn

1875-9114

journal_volume

15

pub_type

杂志文章
  • Impact of an indigent care program on use of resources: experiences at one hospital.

    abstract::Thirty-six indigent patients hospitalized within 6 months of study initiation and who met criteria were enrolled in a 6-month assistance program to determine if provision of both medical care and prescription drugs at no cost would be associated with a change in overall health care charges secondary to a change in the...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.3.217.34781

    authors: Nykamp D,Ruggles D

    更新日期:2000-02-01 00:00:00

  • Colistin: understanding and applying recent pharmacokinetic advances.

    abstract::Colistin, the most widely used polymyxin antibiotic, was originally introduced in the late 1950s before the establishment of the present-day drug approval process. Originally shelved due to toxicity concerns, colistin, in the form of its inactive prodrug colistin methanesulfonate, has undergone a renaissance in the pa...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1484

    authors: Ortwine JK,Kaye KS,Li J,Pogue JM

    更新日期:2015-01-01 00:00:00

  • Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.

    abstract:STUDY OBJECTIVES:To evaluate the occurrence of bleeding and venous thromboembolic (VTE) events in patients receiving rivaroxaban, warfarin, or warfarin with the addition of enoxaparin during the immediate postoperative period following major orthopedic surgery. METHODS:Patients older than 18 years who received at leas...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1888

    authors: Cieri NE,Kusmierski K,Lackie C,Van Opdorp A,Hassan AK

    更新日期:2017-02-01 00:00:00

  • Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.

    abstract:STUDY OBJECTIVE:To investigate the adverse drug reactions (ADRs) from peginterferon alfa-2b plus ribavirin in patients infected with the hepatitis C virus (HCV). DESIGN:Prospective, observational, pharmacovigilance study. SETTING:Gastroenterology department of a French university hospital. PATIENTS:A cohort of conse...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.16.1546.50947

    authors: Bagheri H,Fouladi A,Barange K,Lapeyre-Mestre M,Payen JL,Montastruc JL,Vinel JP

    更新日期:2004-11-01 00:00:00

  • Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents.

    abstract:STUDY OBJECTIVES:To assess the effectiveness of pretreatment with ibuprofen or acetaminophen compared with no pretreatment in decreasing adverse events in children and adolescents receiving the first and second series of pamidronate therapy; and to compare the effectiveness of ibuprofen versus acetaminophen for prevent...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.2.195.33143

    authors: Robinson RE,Nahata MC,Hayes JR,Batisky DL,Bates CM,Mahan JD

    更新日期:2004-02-01 00:00:00

  • Extracorporeal Elimination of Piperacillin/Tazobactam during Molecular Adsorbent Recirculating System Therapy.

    abstract::Use of the Molecular Adsorbent Recirculating System (MARS) as a liver support device continues to grow worldwide. Various components of the MARS circuit remove both protein-bound and water-soluble molecules. Little is known about the extent of the enhanced clearance mechanisms used in MARS therapy on drug elimination....

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1618

    authors: Personett HA,Larson SL,Frazee EN,Nyberg SL,El-Zoghby ZM

    更新日期:2015-08-01 00:00:00

  • Paclitaxel (taxol).

    abstract::Paclitaxel is a novel antineoplastic that effects cytotoxicity by promoting intracellular tubulin polymerization and stabilizes abnormal microtubule structures against depolymerization. Although its clinical development had been hampered by misconceptions about its pharmacology, its scarcity, difficulties extracting i...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1994.tb02785.x

    authors: Kohler DR,Goldspiel BR

    更新日期:1994-01-01 00:00:00

  • Drug and poison information resources on the Internet, Part 1: An introduction.

    abstract::The Internet is an excellent source of drug and poison information. Despite the relative case and minimal costs associated with accessing the Internet, many pharmacists and other health care professionals have been slow to adopt this new technology. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Marra CA,Lynd LD,McKerrow R,Carleton BC

    更新日期:1996-07-01 00:00:00

  • Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.

    abstract::Warfarin is a commonly used oral anticoagulant that is usually initiated after the definitive diagnosis of a certain thromboembolic disorder or disease. Warfarin therapy will usually be prescribed for 6-12 weeks or more, and some patients may continue therapy throughout life, depending on the type of thromboembolic di...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Yamreudeewong W,Johnson JV,Cassidy TG,Berg JT

    更新日期:1996-11-01 00:00:00

  • A case report of warfarin resistance due to azathioprine and review of the literature.

    abstract::A 32-year-old woman with a history of deep vein thrombosis (DVT), steroid-dependent ulcerative colitis, and osteoporosis was prescribed azathioprine for a steroid-sparing effect. Stable, therapeutic international normalized ratios (INRs) were obtained with warfarin 35 mg/week during a 6-week postpartum course to treat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.3.355.34208

    authors: Havrda DE,Rathbun S,Scheid D

    更新日期:2001-03-01 00:00:00

  • Role of the pharmacist.

    abstract::The prevalence of cardiovascular risk factors continues to rise, with considerable emphasis on the upward trends in obesity and diabetes mellitus, which have increased by 46% and 60%, respectively, in the past 10 years. The alarming increase in the prevalence of diabetes and obesity has resulted in the development of ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.12part2.227S

    authors: Bottorff M

    更新日期:2006-12-01 00:00:00

  • Is chlordiazepoxide the rational choice among benzodiazepines?

    abstract::Diazepam is frequently the subject of review by various agencies and institutions charged with determining whether or not to substitute another, more economical drug--in most instances, chlordiazepoxide. A review of the comparative literature has shown that, on clinical and pharmacokinetic grounds, chlordiazepoxide is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1982.tb03181.x

    authors: Baskin SI,Esdale A

    更新日期:1982-03-01 00:00:00

  • Pharmacologic and pharmacokinetic comparison of antianginal agents.

    abstract::Calcium channel blockers, nitrates, and beta blockers are the primary agents used for the treatment of angina. Calcium has a central role in excitation-contraction, action potential generation, and ischemic cell death. The three currently available calcium antagonists are nifedipine, verapamil, and diltiazem. Second-g...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04052.x

    authors: Angaran D

    更新日期:1987-01-01 00:00:00

  • Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial.

    abstract:STUDY OBJECTIVE:To evaluate the effects of topical atorvastatin on the healing process of pressure ulcers in critically ill patients. DESIGN:Randomized, double-blind, placebo-controlled clinical trial. SETTING:Medical-surgical intensive care unit of a university-affiliated teaching hospital in Tehran, Iran. PATIENTS...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/phar.1339

    authors: Farsaei S,Khalili H,Farboud ES,Karimzadeh I,Beigmohammadi MT

    更新日期:2014-01-01 00:00:00

  • Economic analysis of alvimopan for prevention and management of postoperative ileus.

    abstract:STUDY OBJECTIVE:To determine whether alvimopan for prevention of postoperative ileus in patients undergoing small- or large-bowel resection by laparotomy is associated with lower total costs compared with standard care. DESIGN:Pharmacoeconomic analysis using a formal decision model. DATA SOURCE:Four phase III clinica...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/PHAR.1047

    authors: Touchette DR,Yang Y,Tiryaki F,Galanter WL

    更新日期:2012-02-01 00:00:00

  • Successful management of anticoagulation therapy during international travel.

    abstract::Warfarin is considered a high-risk drug because of its narrow therapeutic window, variability in dose response, and multitude of drug and food interactions. Although travel advice is available for patients who are taking warfarin, it is geared toward patients who are traveling to developed countries and tends to be la...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.2012.01019.x

    authors: Truong T,Armor BL

    更新日期:2012-03-01 00:00:00

  • 1992 National Clinical Pharmacy Services Study.

    abstract:STUDY OBJECTIVE:To determine the extent of hospital-based clinical pharmacy services in 1992. DESIGN:National survey with trend comparison to 1989. SETTING:All 1597 United States acute care, general medical-surgical and pediatric hospitals with 50 or more licensed beds and one or more full-time pharmacists (43% of al...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Bond CA,Raehl CL,Pitterle ME

    更新日期:1994-05-01 00:00:00

  • Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.

    abstract:STUDY OBJECTIVE:To determine if transitioning patients from a pharmacist- managed anticoagulation clinic after stabilization of warfarin therapy to physician-managed care alters the quality of anticoagulation care. DESIGN:Retrospective medical record review. SETTING:Pharmacist-managed, urban academic medical center-b...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.1.20

    authors: Garwood CL,Dumo P,Baringhaus SN,Laban KM

    更新日期:2008-01-01 00:00:00

  • Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.

    abstract::The clinical and economic impacts of bacterial resistance are substantial. The development of bacterial resistance during a course of therapy often leads to clinical failure, prolonged hospitalization, increased morbidity, mortality, and increased health care costs. Resistance has been reported to occur most frequentl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Barriere SL

    更新日期:1992-01-01 00:00:00

  • Integrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?

    abstract::The era of the integrase strand transfer inhibitors (INSTIs) for the treatment of human immunodeficiency virus (HIV) infection began with raltegravir in 2007. Since that time, several other INSTIs have been introduced including elvitegravir, dolutegravir, and, most recently, bictegravir, that have shown great utility ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2246

    authors: Brooks KM,Sherman EM,Egelund EF,Brotherton A,Durham S,Badowski ME,Cluck DB

    更新日期:2019-05-01 00:00:00

  • Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy and safety of a new combination product, enalapril-diltiazem ER, when administered over the long term. DESIGN:Open-label, titration to response, with treatment lasting 46 weeks after a 6-week, double-blind phase. SETTING:Medical clinics in the private and academic sectors. PA...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Applegate W,Cohen JD,Wolfson P,Davis A,Green S

    更新日期:1997-01-01 00:00:00

  • Interpreting meta-analyses of pharmacologic interventions: the pitfalls and how to identify them.

    abstract::Meta-analyses are key components of evidence-based decision making. The numbers of meta-analyses published in different areas of health care increased dramatically during the past 10 years. Many of them covered different pharmacologic interventions, making them useful resources to clinical pharmacists. Although a well...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.9.741.31541

    authors: Etminan M,Levine M

    更新日期:1999-06-01 00:00:00

  • Association of GGH Promoter Methylation Levels with Methotrexate Concentrations in Chinese Children with Acute Lymphoblastic Leukemia.

    abstract:BACKGROUND:It is known that γ-glutamyl hydrolase (GGH) is involved in the disposition of methotrexate (MTX), and GGH activity is regulated by DNA methylation in acute lymphoblastic leukemia (ALL) cells. The present study explores the methylation status of the GGH promoter in peripheral blood and its association with MT...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2430

    authors: Wang SM,Kong XY,Li M,Sun LL,Yan D

    更新日期:2020-07-01 00:00:00

  • Immune-mediated coagulopathy: a case report.

    abstract::Surgical hemostasis may be achieved by using a number of physical, chemical, or biologic methods. One such method is with topical thrombin; however, one member of that class of drugs, bovine-derived thrombin, is associated with potentially serious consequences such as development of immune-mediated coagulopathy. This ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.pt2.13S

    authors: Naoum JJ

    更新日期:2009-07-01 00:00:00

  • Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.

    abstract::Exenatide is an incretin mimetic indicated for the treatment of type 2 diabetes mellitus in combination with a sulfonylurea, a thiazolidinedione, metformin, or metformin plus a sulfonylurea or thiazolidinedione. Exenatide lowers postprandial blood glucose levels by stimulating glucose-dependent insulin secretion, inhi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.10.1449

    authors: Sheffield CA,Kane MP,Busch RS

    更新日期:2007-10-01 00:00:00

  • Etomidate: a new intravenous anesthetic induction agent.

    abstract::Currently available anesthetic induction agents provide adequate hypnosis but are not ideal, particularly in the high risk patient (ASA class III-V), because most cause myocardial and/or respiratory depression and some have other important side effects. Etomidate was recently marketed as an intravenous anesthetic indu...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1983.tb03266.x

    authors: Giese JL,Stanley TH

    更新日期:1983-09-01 00:00:00

  • Effect of patient withdrawal on a study evaluating pharmacist management of hypertension.

    abstract:STUDY OBJECTIVES:To examine potential threats to internal and external study validity caused by differential patient withdrawal from a randomized controlled trial evaluating pharmacist management of hypertension, to compare the characteristics of patients who withdrew with those of patients who completed the study, and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1592/phco.26.11.1565

    authors: Rozenfeld Y,Hunt JS

    更新日期:2006-11-01 00:00:00

  • Early-onset pentamidine-associated second-degree heart block and sinus bradycardia: case report and review of the literature.

    abstract::Although various manifestations of pentamidine-induced cardiotoxicity have been reported, to our knowledge, second-degree heart block associated with this agent has not been described. In addition, cardiac adverse effects usually develop after at least 6 days of therapy. We describe a 54-year-old, human immunodeficien...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.6.899

    authors: Antoniou T,Gough KA

    更新日期:2005-06-01 00:00:00

  • Achieving target antifactor Xa activity with a heparin protocol based on sex, age, height, and weight.

    abstract:STUDY OBJECTIVES:To develop and validate an improved unfractionated heparin (UFH) dosage protocol, using antifactor Xa levels as the outcome variable. DESIGN:Prospective case series. SETTING:A 625-bed, adults-only private, tertiary care teaching hospital. PATIENTS:Three hundred seventy-two patients receiving UFH for...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.8.713.36067

    authors: Rosborough TK,Shepherd MF

    更新日期:2004-06-01 00:00:00

  • Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration.

    abstract:STUDY OBJECTIVE:To compare the effectiveness of weight-management medications used to assist with weight loss in real-world clinical practice in the Veterans Health Administration (VHA). DESIGN:Retrospective, multicenter, observational cohort study. DATA SOURCE:National VA Corporate Data Warehouse. PATIENTS:A total ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.2048

    authors: Grabarczyk TR

    更新日期:2018-01-01 00:00:00